Business & Industry

Chinese pharma giant to build plant in Ethiopia

The government of Ethiopia has hailed the advent of cheaper medicines with the promised opening of a new Chinese pharmaceutical plant in the country. Humanwell Healthcare, China’s biggest pharmaceutical manufacturing company, will invest $91m (2 billion Birr) for the construction of a plant in Ethiopia – its second investment destination on the continent, after Mali,

aspen

Aspen buys rights to Astra Zeneca’s anesthetics

South Africa-based Aspen Pharmacare purchased the rights to AstraZeneca’s anesthetics portfolio outside the US in an externalization deal that will provide funds for the latter to invest in new drugs. Under the terms of the agreement, AstraZeneca is entitled to an upfront payment of $520 million, sales-related payments of $250 million and trademark royalties. Aspen,

IFC extends facility to Nigeria pharmacy chain, HealthPlus

The International Finance Corporation (IFC), a member of the World Bank Group, has announced an agreement with HealthPlus Limited and CasaBella International Limited to provide a $5 million loan facility that will help the two companies expand pharmaceutical and personal care services in Nigeria.

NovaBay-Pharma-Logo-101912

NovaBay signs distribution agreement with the Biopharm Group

NovaBay Pharmaceuticals, a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, has signed an exclusive distribution agreement for NovaBay’s NeutroPhase Skin and Wound Cleanser with the Biopharm Group, a leading pharmaceutical company in the Middle East, headquartered in Cairo, Egypt. Under the terms of the agreement, Biopharm will market NeutroPhase

Deals

OphamEdit-620x264

FMO, Adenia in leading pharmaceutical distributor in Madagascar

In the latest deal for its €96 million Fund III, Mauritius-headquartered private equity firm Adenia Partners is taking an undisclosed stake in Opham, a pharmaceutical products wholesaler in Madagascar. A family office and Dutch Development bank FMO invested alongside Adenia in the deal. The capital will be used to expand Opham’s operations, which currently distributes more

Policy & Regulatory Affairs

The Medicines Patent Pool Signs First Sub-licences for Hepatitis C Medicine Daclatasvir

Four companies to help speed access to curative direct-acting antiviral in 112 low- and middle-income countries The Medicines Patent Pool (MPP) has announced its first round of sub-licences for the generic production of Bristol-Myers Squibb’s daclatasvir, a direct-acting antiviral that is proven to help cure multiple genotypes of the hepatitis C virus. Generic companies Cipla,

The Medicines Patent Pool Signs First Sub-licences for Hepatitis C Medicine Daclatasvir

Four companies to help speed access to curative direct-acting antiviral in 112 low- and middle-income countries The Medicines Patent Pool (MPP) has announced its first round of sub-licences for the generic production of Bristol-Myers Squibb’s daclatasvir, a direct-acting antiviral that is proven to help cure multiple genotypes of the hepatitis C virus. Generic companies Cipla,

Pharma Projects

JohnsonJohnson_Logo

Johnson & Johnson unveils R300m plant makeover, targets growth in Nigeria

Johnson & Johnson have unveiled their modernised manufacturing plant in Cape Town, South Africa yesterday. The plant, located in Retret, underwent a R300 million upgrade to and is responsible for supplying more than 28 markets within Sub Sahara Africa. Pharmaceutical exports from South Africa amounted to R1.6 billion in 2013, of which more than half went

Plans set for new ARV production plant in Ghana

Oxford International Biomedical Ventures (OIBV), the ‘commercial arm’ of  United Kingdom-based charitable organisation Oxford International Biomedical Centre (OIBC) and the Government of Ghana (GoG) led by the Ministry of Environment, Science and Technology (MEST), are set to jointly establish a plant to manufacture anti-retroviral drugs and drugs for Priority Endemic Diseases in Ghana, OIBC said in a

Press Releases

International

Temazepam_10mg_tablets-1

UNAIDS and CCCMHPIE Sign Agreement to Support China-Africa Health Collaboration

The Joint United Nations Program on HIV/AIDS (UNAIDS) China Office signed a cooperation agreement with the China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE) in Shanghai, China in June 2016, aiming to further effect the China-Africa health collaboration, especially in terms of local production of pharmaceuticals and health commodities

Temazepam_10mg_tablets-1

UNAIDS and CCCMHPIE Sign Agreement to Support China-Africa Health Collaboration

The Joint United Nations Program on HIV/AIDS (UNAIDS) China Office signed a cooperation agreement with the China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE) in Shanghai, China in June 2016, aiming to further effect the China-Africa health collaboration, especially in terms of local production of pharmaceuticals and health commodities

Top